Molecular characteristics of colorectal cancer subtypes

Colorectal cancer (CRC) exhibits significant molecular heterogeneity, impacting diagnosis, prognosis, and treatment strategies. This study explored consensus molecular subtypes (CMS) to better understand CRC’s molecular diversity and assess their potential as clinical biomarkers. Bioinformatics methods were employed to identify biological differences associated with CMS and to develop tools for evaluating their application in clinical settings.
The research reviewed existing models of CRC heterogeneity and demonstrated how CMS classifications could inform clinical decision-making. CMS-specific models were created to investigate subtype mechanisms and identify targeted therapies, showing the association of metabolic activation and enterocyte-like differentiation in CMS3. Additionally, a classification tool was developed to effectively analyze archival samples, enabling the examination of transcriptomic and genomic data from early-stage CRC lesions. This analysis identified associations between CMS subtypes, CRC development, and genetic alterations during tumor progression.
Furthermore, the study evaluated the predictive value of CMS for chemotherapy response in non-metastatic CRC, providing insights into the effectiveness of standard adjuvant chemotherapy based on CMS classification. The findings highlight the significance of CMS in CRC research and clinical practice, suggesting that their implementation could support more personalized treatment approaches by selecting patients with a higher likelihood of benefiting from these treatments.